SNP market view: opportunities, technologies, and products.
作者信息
Wypgant Matthew
机构信息
Matthew Wygant Biotech Writing, Los Gatos, CA 95032, USA.
出版信息
Biotechniques. 2002 Jun;Suppl:78-80, 82, 84 passim.
PMID:12083402
Abstract
摘要
相似文献
1
SNP market view: opportunities, technologies, and products.单核苷酸多态性（SNP）市场展望：机遇、技术与产品
Biotechniques. 2002 Jun;Suppl:78-80, 82, 84 passim.
2
Genomic sciences and the medicine of tomorrow.基因组科学与未来医学。
Nat Biotechnol. 1996 Nov;14(11):1516-8. doi: 10.1038/nbt1196-1516.
3
R&D deals boom in 2004.2004年研发交易蓬勃发展。
Nat Biotechnol. 2005 Sep;23(9):1036. doi: 10.1038/nbt0905-1036.
4
BeadArray-based solutions for enabling the promise of pharmacogenomics.基于微珠芯片的解决方案，助力实现药物基因组学的前景。
Biotechniques. 2005 Oct;39(4):583-8.
5
Biotech's billion dollar breakthrough.生物技术领域的十亿美元突破。
Fortune. 2003 May 26;147(10):96-8, 100, 103.
6
Biotech drugs come of age; policymakers take notice.生物科技药物走向成熟；政策制定者予以关注。
Health Aff (Millwood). 2006 Sep-Oct;25(5):1202-3. doi: 10.1377/hlthaff.25.5.1202.
7
Applying technologies towards safe and effective medicines.将技术应用于安全有效的药物。
Biotechniques. 2005 Oct;39(4):563-4.
8
The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.药物遗传学的前景：评估疾病和患者分层的前景。
Stud Hist Philos Biol Biomed Sci. 2006 Sep;37(3):583-601. doi: 10.1016/j.shpsc.2006.06.002. Epub 2006 Aug 23.
9
Screening for drug discovery: the leading question.药物发现的筛选：首要问题。
Nature. 2002 Jul 25;418(6896):453-9. doi: 10.1038/418453a.
10
Pharmacogenetics initiative galvanizes public and private sectors.药物遗传学计划激励了公共和私营部门。
Nature. 2001 Mar 15;410(6826):393-4. doi: 10.1038/35066732.
引用本文的文献
1
Gene expression profiling: from microarrays to medicine.基因表达谱分析：从微阵列到医学。
J Clin Immunol. 2004 May;24(3):213-24. doi: 10.1023/B:JOCI.0000025443.44833.1d.
Zotero 插件